Literature DB >> 23345131

Functionalizing αvβ3- or α5β1-selective integrin antagonists for surface coating: a method to discriminate integrin subtypes in vitro.

Florian Rechenmacher1, Stefanie Neubauer, Julien Polleux, Carlos Mas-Moruno, Mariarosaria De Simone, Elisabetta Ada Cavalcanti-Adam, Joachim P Spatz, Reinhard Fässler, Horst Kessler.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23345131     DOI： 10.1002/anie.201206370

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  17 in total

1.  In vivo biokinetic and metabolic characterization of the ⁶⁸Ga-labelled α5β1-selective peptidomimetic FR366.

Authors:  Calogero D'Alessandria; Karolin Pohle; Florian Rechenmacher; Stefanie Neubauer; Johannes Notni; Hans-Jürgen Wester; Markus Schwaiger; Horst Kessler; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-24       Impact factor: 9.236

Review 2.  Regulation of integrin and growth factor signaling in biomaterials for osteodifferentiation.

Authors:  Qiang Wei; Theresa L M Pohl; Anja Seckinger; Joachim P Spatz; Elisabetta A Cavalcanti-Adam
Journal:  Beilstein J Org Chem       Date:  2015-05-13       Impact factor: 2.883

Review 3.  Tumor Targeting via Integrin Ligands.

Authors:  Udaya Kiran Marelli; Florian Rechenmacher; Tariq Rashad Ali Sobahi; Carlos Mas-Moruno; Horst Kessler
Journal:  Front Oncol       Date:  2013-08-30       Impact factor: 6.244

4.  Biofunctionalization strategies on tantalum-based materials for osseointegrative applications.

Authors:  Carlos Mas-Moruno; Beatriz Garrido; Daniel Rodriguez; Elisa Ruperez; F Javier Gil
Journal:  J Mater Sci Mater Med       Date:  2015-02-11       Impact factor: 3.896

5.  Substrate engagement of integrins α5β1 and αvβ3 is necessary, but not sufficient, for high directional persistence in migration on fibronectin.

Authors:  Dimitris Missirlis; Tamás Haraszti; Catharina v C Scheele; Tina Wiegand; Carolina Diaz; Stefanie Neubauer; Florian Rechenmacher; Horst Kessler; Joachim P Spatz
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

6.  Towards the cell-instructive bactericidal substrate: exploring the combination of nanotopographical features and integrin selective synthetic ligands.

Authors:  Roberta Fraioli; Penelope M Tsimbouri; Leanne E Fisher; Angela H Nobbs; Bo Su; Stefanie Neubauer; Florian Rechenmacher; Horst Kessler; Maria-Pau Ginebra; Matthew J Dalby; José M Manero; Carlos Mas-Moruno
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

7.  A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins.

Authors:  Tobias G Kapp; Florian Rechenmacher; Stefanie Neubauer; Oleg V Maltsev; Elisabetta A Cavalcanti-Adam; Revital Zarka; Ute Reuning; Johannes Notni; Hans-Jürgen Wester; Carlos Mas-Moruno; Joachim Spatz; Benjamin Geiger; Horst Kessler
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

8.  Fibronectin promotes directional persistence in fibroblast migration through interactions with both its cell-binding and heparin-binding domains.

Authors:  Dimitris Missirlis; Tamás Haraszti; Horst Kessler; Joachim P Spatz
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

9.  Synthetic extracellular matrices with tailored adhesiveness and degradability support lumen formation during angiogenic sprouting.

Authors:  Jifeng Liu; Hongyan Long; Dagmar Zeuschner; Andreas F B Räder; William J Polacheck; Horst Kessler; Lydia Sorokin; Britta Trappmann
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

10.  Hydrogel micropillars with integrin selective peptidomimetic functionalized nanopatterned tops: a new tool for the measurement of cell traction forces transmitted through αvβ3- or α5β1-integrins.

Authors:  Sabri Rahmouni; Aaron Lindner; Florian Rechenmacher; Stefanie Neubauer; Tariq Rashad Ali Sobahi; Horst Kessler; Elisabetta Ada Cavalcanti-Adam; Joachim Pius Spatz
Journal:  Adv Mater       Date:  2013-08-05       Impact factor: 30.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.